is retatrutide safe for diabetics UK 2026: Phase 3 Results Retatrutide Promises Big Weight Loss,

In a study published in the New England Journal of Medicine, people lost 20.9% of their starting weight after roughly a year on tirzepatide

GLP-1 medications are primarily used to treat type 2 diabetes and to support weight management

Food Chem Toxicol 2010, 48 (1), 345-55.

But they also create a nutritional paradox

ACSL4 deletion or treatment with liproxstatin-1, an inhibitor of ferroptosis, significantly reduced 4-hydroxynonenal (4-HNE) levels, while the level of 4-HNE in esophageal cancer tissues after radiotherapy was significantly associated with better clinical prognosis of cancer patients (257)

The shedding will appear two to four months later